Implementation of Kidney Cancer-Specific Training for Clinical Research Nurses
Abstract
During the review period, investigators and mentors are credited in initiating a renal cell cancer clinical research nurse-specific training and orientation program for three clinical research nurse trainees. We have also mentored the clinical research nurse trainees in the beginning stages of the research project. Clinical trial development has been critical for improving the outcomes of patients with kidney cancer, with the approval of 13 new treatments in the last 15 years. With proper oversight, clinical trials provide patients safe, early access to new medications that are promising. However, access to these novel treatments can be limited by the availability of expertise. Clinical research nurses (CRNs) are critical members of the patient's medical team that ensure that new medications can be delivered ethically, safely, and effectively. We hypothesize that having CRNs that are specialized in kidney cancer will improve the safety and tolerability of patients treated on clinical trials by improving the management of side effects and making sure patients adhere to the schedule and rules of the clinical trial. To improve the access of disease-specific CRNs, we propose a project with two specific aims: Establish a kidney cancer-specific CRN training program, and Perform a pilot project to study the safety and quality of care when integrating telemedicine into clinical trial nursing.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2023
- Accession Number
- AD1223923
Entities
People
- Alisa Ritea
- Chung-Han Lee
- Cindy Puzio
- Lauren Evans
- Patricia Fischer
- Robert Goodman
- Robert Motzer
- Susanne Gornell
Organizations
- Memorial Sloan Kettering Cancer Center